ToxSci Advance Access published online on August 10, 2005
Toxicological Sciences, doi:10.1093/toxsci/kfi282
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2N8
* To whom correspondence should be addressed. We recently demonstrated that heavy metals, Hg2+, Pb2+, and Cu2+ induced Cyp1a1 gene expression, yet the mechanisms involved remain unknown. To explore the molecular mechanisms involved in the modulation of Cyp1a1 by heavy metals, Hepa 1c1c7 cells were treated with the metals in the presence and absence of TCDD, a potent Cyp1a1 inducer. Time-dependent effect study showed that all metals significantly induced the basal Cyp1a1 mRNA. This was apparent 3 h after treatment and levels remained elevated for at least 24 h. At the inducible level, Hg2+ and Pb2+ further increased, while Cu2+ decreased, the TCDD-mediated induction of Cyp1a1 mRNA. The RNA synthesis inhibitor, actinomycin D, completely blocked the Cyp1a1 induction by heavy metals. The protein synthesis inhibitor, cycloheximide, and 26S proteasome inhibitor, MG-132, superinduced the metal-mediated induction of Cyp1a1 mRNA. In addition, all three metals induced AhR/XRE binding, suggesting an AhR-dependent mechanism. Cyp1a1 mRNA and protein decay experiments showed that the three metals did not significantly affect the half-life of mRNA; however, significantly decreased the degradation rate of its protein, implying a posttranslational regulation of the Cyp1a1 by the heavy metals. A significant decrease in TCDD- mediated induction of Cyp1a1 activity associated with an increase in HO-1 mRNA and a decrease in cellular heme content was observed after all metals treatment. This suggests that heme degradation plays a role in reducing Cyp1a1 activity. This is the first demonstration that heavy metals can directly induce Cyp1a1 gene expression in an AhR-dependent manner through transcriptional and posttranslational mechanisms.
Received May 25, 2005
Accepted August 4, 2005
Biotransformation and Toxicokinetics
Regulatory Mechanisms Modulating the Expression of Cytochrome P450 1a1 Gene by Heavy Metals
Ayman O.S. El-Kadi, E-mail: aelkadi{at}pharmacy.ualberta.ca
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Anwar-Mohamed and A. O. S. El-Kadi Down-Regulation of the Carcinogen-Metabolizing Enzyme Cytochrome P450 1a1 by Vanadium Drug Metab. Dispos., September 1, 2008; 36(9): 1819 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Korashy, A. Shayeganpour, D. R. Brocks, and A. O.S. El-Kadi Induction of Cytochrome P450 1A1 by Ketoconazole and Itraconazole but not Fluconazole in Murine and Human Hepatoma Cell Lines Toxicol. Sci., May 1, 2007; 97(1): 32 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Korashy and A. O. S. El-Kadi TRANSCRIPTIONAL REGULATION OF THE NAD(P)H:QUINONE OXIDOREDUCTASE 1 AND GLUTATHIONE S-TRANSFERASE YA GENES BY MERCURY, LEAD, AND COPPER Drug Metab. Dispos., January 1, 2006; 34(1): 152 - 165. [Abstract] [Full Text] [PDF] |
||||

